Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hims & Hers Health, Inc.HIMS · Entity 1878 | Chief Operating Officer | May 12, 2025 | May 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hims & Hers Health, Inc.
Report date May 12, 2025 · Filed May 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 805,083 |
Ending reported balance
After 2025-05-12 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2025-05-12 · Exercise / conversion · Acquired 33,333 · Balance 838,416 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. Row 2 · 2025-05-12 · Sale · Disposed 13,786 · Balance 824,630 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 3 · 2025-05-12 · Sale · Disposed 6,801 · Balance 817,829 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F3: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 4 · 2025-05-12 · Sale · Disposed 7,556 · Balance 810,273 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F4: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Row 5 · 2025-05-12 · Sale · Disposed 5,190 · Balance 805,083 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F5: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.43 · Expires 2030-05-13 | Direct | 693,795 |
Reported balance
After 2025-05-12 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-05-12 · Exercise / conversion · Disposed 33,333 · Balance 693,795 F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person. F6: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 26, 2024 by the Reporting Person.
F2: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $54.405 - $55.395. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $55.405 - $56.315. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $56.425 - $57.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $57.45 - $58.265. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 1,719,884 shares of Hims, Inc., with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 779,073 shares of the Company with an exercise price of $1.75. 100% of the shares subject to the option have vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2024 Filed Sep 5, 2024 18:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 11,749 | $0.40 | $4,699.60 |
DisclosureSEC source: 0001773751-24-000284 · wk-form4_1725575824.xml · nonDerivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 597,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 18:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 11,884 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000284 · wk-form4_1725575824.xml · derivative · entry 10 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 484,176 Underlying: Class A Common Stock · 11,884 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 18:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 5,035 | $14.49 | $72,957.15 |
DisclosureSEC source: 0001773751-24-000284 · wk-form4_1725575824.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 585,800 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.335 - $14.665. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 18:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,849 | $14.49 | $99,268.04 |
DisclosureSEC source: 0001773751-24-000284 · wk-form4_1725575824.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 590,835 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $14.33 - $14.70. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 18:37 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 11,884 | $0.40 | $4,753.60 |
DisclosureSEC source: 0001773751-24-000284 · wk-form4_1725575824.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 597,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| August 07, 2024 Filed Aug 7, 2024 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 16,649 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · derivative · entry 11 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 496,060 Underlying: Class A Common Stock · 16,649 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F7 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| August 07, 2024 Filed Aug 7, 2024 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 16,649 | $16.22 | $269,998.50 |
DisclosureSEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 8 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 585,800 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $15.89-$16.57. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 07, 2024 Filed Aug 7, 2024 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 16,649 | $0.40 | $6,659.60 |
DisclosureSEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 7 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 602,449 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 16,784 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · derivative · entry 10 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 512,709 Underlying: Class A Common Stock · 16,784 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F7 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 7,260 | $17.37 | $126,117.09 |
DisclosureSEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 585,800 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.21 - $17.74. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,524 | $16.71 | $159,190.80 |
DisclosureSEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 593,060 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $16.09-$17.08. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 06, 2024 Filed Aug 7, 2024 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 16,784 | $0.40 | $6,713.60 |
DisclosureSEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 602,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 16,784 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · derivative · entry 9 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 529,493 Underlying: Class A Common Stock · 16,784 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F7 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 10,351 | $17.71 | $183,327.60 |
DisclosureSEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 585,800 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $17.26-$18.045. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,433 | $16.82 | $108,174.75 |
DisclosureSEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 596,151 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $16.22-$17.21. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| August 05, 2024 Filed Aug 7, 2024 20:30 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 16,784 | $0.40 | $6,713.60 |
DisclosureSEC source: 0001773751-24-000252 · wk-form4_1723077018.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 602,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| July 09, 2024 Filed Jul 9, 2024 18:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 17,625 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · derivative · entry 9 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 546,277 Underlying: Class A Common Stock · 17,625 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| July 09, 2024 Filed Jul 9, 2024 18:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 17,625 | $20.42 | $359,886.64 |
DisclosureSEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · nonDerivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 585,800 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.92 - $20.695. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 09, 2024 Filed Jul 9, 2024 18:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 17,625 | $0.40 | $7,050.00 |
DisclosureSEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · nonDerivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 603,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 18:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 17,625 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · derivative · entry 8 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 563,902 Underlying: Class A Common Stock · 17,625 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 18:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 17,625 | $20.90 | $368,380.13 |
DisclosureSEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · nonDerivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 585,800 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.48 - $21.40. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 08, 2024 Filed Jul 9, 2024 18:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 17,625 | $0.40 | $7,050.00 |
DisclosureSEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 603,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 18:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 17,625 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · derivative · entry 7 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 581,527 Underlying: Class A Common Stock · 17,625 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F5 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 18:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 17,625 | $20.51 | $361,561.01 |
DisclosureSEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 585,800 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F2 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.05 - $20.745. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 18:22 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 17,625 | $0.40 | $7,050.00 |
DisclosureSEC source: 0001773751-24-000220 · wk-form4_1720563736.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 603,425 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 17:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 26,133 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 10 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 392,008 Underlying: Class A Common Stock · 26,133 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F6 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. F6 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2024. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 17:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 1,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 9 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,665 Underlying: Class A Common Stock · 1,222 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 17:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 1,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 8 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,877 Underlying: Class A Common Stock · 1,626 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 17:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 8,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 7 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,886 Underlying: Class A Common Stock · 8,295 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 17:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 49 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146 Underlying: Class A Common Stock · 49 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 17:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,435 Underlying: Class A Common Stock · 811 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F5 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. F5 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after March 15, 2021. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 17:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 18,713 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,988 Underlying: Class A Common Stock · 18,713 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F4 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. F4 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 17:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionRestricted Stock Unit · Derivative | 16,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · derivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,270 Underlying: Class A Common Stock · 16,297 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. F3 · derivative.exercise_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. F3 · derivative.expiration_date: The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2023. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 17:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Tax withholdingClass A Common Stock | 28,778 | $23.75 | $683,477.50 |
DisclosureSEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 585,800 F2 · shares: The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs. Read SEC document |
| June 14, 2024 Filed Jun 18, 2024 17:27 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 73,146 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001773751-24-000199 · wk-form4_1718746020.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 614,578 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU. Read SEC document |
| June 05, 2024 Filed Jun 5, 2024 18:46 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 17,625 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · derivative · entry 12 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 599,152 Underlying: Class A Common Stock · 17,625 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F9 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| June 05, 2024 Filed Jun 5, 2024 18:46 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 3,562 | $21.66 | $77,144.02 |
DisclosureSEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 9 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 541,432 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.595 - $21.715. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 05, 2024 Filed Jun 5, 2024 18:46 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 14,063 | $21.25 | $298,833.12 |
DisclosureSEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 8 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 544,994 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.60 - $21.59. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 05, 2024 Filed Jun 5, 2024 18:46 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 17,625 | $0.40 | $7,050.00 |
DisclosureSEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 7 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 559,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| June 04, 2024 Filed Jun 5, 2024 18:46 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 17,625 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · derivative · entry 11 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 616,777 Underlying: Class A Common Stock · 17,625 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F9 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| June 04, 2024 Filed Jun 5, 2024 18:46 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 8,332 | $20.11 | $167,590.68 |
DisclosureSEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 6 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 541,432 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F6 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.50 - $20.49. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2024 Filed Jun 5, 2024 18:46 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 9,293 | $20.69 | $192,269.38 |
DisclosureSEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 5 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 549,764 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.495 - $20.855. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 04, 2024 Filed Jun 5, 2024 18:46 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 17,625 | $0.40 | $7,050.00 |
DisclosureSEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 4 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 559,057 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 18:46 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 70,506 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · derivative · entry 10 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 634,402 Underlying: Class A Common Stock · 70,506 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F9 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 18:46 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,100 | $20.86 | $127,219.77 |
DisclosureSEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 3 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 541,432 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F4 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $20.70 - $21.14. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 18:46 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 64,406 | $20.32 | $1,308,729.92 |
DisclosureSEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 2 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 547,532 F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F3 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $19.715 - $20.68. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 18:46 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionClass A Common Stock | 70,506 | $0.40 | $28,202.40 |
DisclosureSEC source: 0001773751-24-000160 · wk-form4_1717627562.xml · nonDerivative · entry 1 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 611,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F2 · balance_after: Includes 2,500 shares acquired on May 20, 2024, under the Hims & Hers Health, Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| May 03, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | Exercise / conversionStock Option (right to buy) · Derivative | 11,750 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · derivative · entry 14 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 704,908 Underlying: Class A Common Stock · 11,750 shares Expires 2028-03-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F8 · derivative.exercise_date: Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 2,043,499 shares of Class A common stock of Hims, Inc., with an exercise price of $0.18. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 1,086,723 shares of the Company with an exercise price of $0.40. 100% of the shares subject to the option have vested. Read SEC document |
| May 03, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 700 | $12.29 | $8,599.50 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 11 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 538,932 F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F7 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $12.24 - $12.32. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 03, 2024 Filed May 3, 2024 18:38 UTC | Hims & Hers Health, Inc. HIMS · Entity 1878 | SaleClass A Common Stock | 6,014 | $11.57 | $69,576.57 |
DisclosureSEC source: 0001773751-24-000123 · wk-form4_1714775881.xml · nonDerivative · entry 10 Baird Melissa · CIK 0001837815 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 539,632 F1 · kind: The stock option exercises and related sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 21, 2023 by the Reporting Person. F5 · price: Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $11.21 - $12.17. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.